Summary
This study examined the effect of over-expression of sFlt-1 by trophoblasts on the barrier function of glomerular endothelial cells and the role of VEGF in this process in order to explore the pathogenesis of glomerular disease in preeclampsia. SFlt-1 expression in the human trophoblasts (TEV-1 cells) was enhanced by transfecting sFlt-1 plasmid DNA into TEV-1 cells. The monolayer barrier function of glomerular endothelial cells (ciGEnCs) was determined by measuring the fluorescence intensity of bovine serum albumin (BSA) that crossed the monolayer of glomerular endothelial cells. The results showed that the over-expression of sFlt-1 by TEV-1 cells led to the barrier dysfunction of ciGEnCs, and the exogenous VEGF could alleviate the ciGEnCs dysfunction resulting from the over-expression of sFlt-1 to a certain extent. It was concluded that the dysregulation of sFlt-1 and VEGF in preeclamptic pregnancy may contribute to the barrier dysfunction of glomerular endothelial cells, and VEGF may play an important role in maintaining the barrier function of glomerular endothelial cells, but it may not be the sole factor.
Similar content being viewed by others
References
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ, 2005,330(7491):565
Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol, 2007,18(8):2281–2284
Henao DE, Saleem MA, Cadavid AP. Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy, 2010,29(1):10–20
Moran P, Baylis PH, Lindheimer MD, et al. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol, 2003,14:648–652
Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med, 2008,359(8):800–809
Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG, 2003,110(9):831–836
Karumanchi SA, Stillman IE. In vivo rat model of preeclampsia. Methods Mol Med, 2006,122:393–399
Doi K, Noiri E, Fujita T. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol, 2010,8(1):122–128
Tang Z, Ren H, Yang G, et al. Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy. Am J Nephrol, 2005,25(6):579–585
Wakelin SJ, Marson L, Howie SE, et al. The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiol, 2004,98(3):73–79
Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig, 2005,12:e21–e32
Satchell SC, Tasman CH, Singh A, et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int, 2006,69(9):1633–1640
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001,25(4):402–408
Du H, Liu HY, Zhao J, et al. Effects of maternal serum on permeability of glomerular endothelial cell membrane. J Huazhong Univ Sci Technol [Med Sci], 2011,31(1):17–20
Zhou Q, Liu HY, Qiao FY, et al. VEGF deficit is involved in endothelium dysfunction in preeclampsia. J Huazhong Univ Sci Technol [Med Sci], 2010,30(3): 370–374
Zhou Q, Qiao FY, Zhao C, et al. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: an implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia. Cell Biol Int, 2011,35(1):61–66
Leeuwis JW, Nguyen TQ, Dendooven A, et al. Targeting podocyte-associated diseases. Adv Drug Deliv Rev, 2010,62(14):1325–1336
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004,350(7):672–683
Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest, 2003,111(5):649–658
Li Z, Zhang Y, Ying Ma J, et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension, 2007,50:686–692
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, J., Liu, H., Du, H. et al. Upregulation of sFlt-1 by trophoblasts induces the barrier dysfunction of glomerular endothelial cells. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 815–818 (2011). https://doi.org/10.1007/s11596-011-0682-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-011-0682-y